One Year Study to Evaluate Three Different Adjuvanted Doses of the Recombinant Plague Vaccine (rF1 and rV Antigens)
Clinical trial NCT00246467 · COMPLETED
Trial details
- NCT number
- NCT00246467
- Sponsor
- PharmAthene UK Limited
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2005-10-01
- Primary completion
- 2007-04-01
- Enrollment
- 123
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.